InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cooper Matthew T, Directeur Scientifique. Insider active across 2 companies, notably Progenity, INC.. Aggregated, 6 disclosures have been logged. The latest transaction was disclosed on 15 November 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€2,123700 shares@ €3.032872.9% of flow
Common Stock
SEC:0000899243-21-045044·
€2,123700 shares@ €3.032824.8% of flow
Common Stock
SEC:0000899243-21-045044:0·
€788560 shares@ €1.407427.1% of flow
Common Stock
SEC:0000899243-21-033251·
€788560 shares@ €1.40749.2% of flow
Common Stock
SEC:0000899243-21-033251:0·
€2,7361,400 shares@ €1.9541100.0% of flow
Common Stock
SEC:0000899243-21-019668·
€2,7361,400 shares@ €1.954132.0% of flow
Common Stock
SEC:0000899243-21-019668:0·
6 of 6 declarations
About Cooper Matthew T
Matthew T. Cooper is the Chief Scientific Officer and General Manager, Diagnostics at Progenity, Inc. In his role, he is responsible for the scientific direction and innovation within the company. His expertise is essential for the development of advanced diagnostic solutions at Progenity.
